Successful Mobilization, Intra-Apheresis Recruitment, and Harvest of Hematopoietic Progenitor Cells by Addition of Plerixafor and Subsequent Large-Volume Leukapheresis
Transfusion Medicine and Hemotherapy2013Vol. 40(4), pp. 251–257
Citations Over Time
Abstract
Plerixafor and G-CSF mobilization or the addition of plerixafor during non-optimal chemotherapy and G-CSF mobilization together with LVL enabled, independent of leukocyte count and even without detectable CD34+ cells before addition of plerixafor, sufficient harvest of HPC numbers for transplantation. Addition of plerixafor during chemotherapy and G-CSF mobilization led to an increased intra-apheresis recruitment and a significantly higher yield of CD34+ cells compared to plerixafor and G-CSF steady-state mobilized patients.
Related Papers
- → Clinical experience with a simple algorithm for plerixafor utilization in autologous stem cell mobilization(2012)33 cited
- → The current status in hematopoietic stem cell mobilization(2015)13 cited
- → Mobilized and apheresis‐collected endothelial progenitor cells with plerixafor(2022)4 cited
- → Can every patient be mobilized?(2010)8 cited
- → Method of Autologous Stem Cell Mobilization Does Not Influence Transplant Outcome(2013)